Randomized, Phase III Study of Early Intervention with Venetoclax
and Obinutuzumab Versus Delayed Therapy with Venetoclax and
Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk
Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic
Lymphoma (CLL/SLL): EVOLVE CLL/SLL Study
Please contact us for more information or to learn if you are eligible to participate.
